Carsten Carlberg

Q: What Schools Are Affiliated With Carsten Carlberg

Carsten Carlberg is affiliated with the following schools: University of Luxembourg, University of Eastern Finland, Free University of Berlin, University of Helsinki

Carsten Carlberg's AcademicInfluence.com Rankings

Carsten Carlberg

Biology

#4560

World Rank

#6789

Historical Rank

Biochemistry

#750

World Rank

#853

Historical Rank

biology Degrees

Download Badge

Biology

Carsten Carlberg's Degrees

PhD Biochemistry University of Helsinki
Masters Biochemistry University of Helsinki

Why Is Carsten Carlberg Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Carsten Carlberg is a German biochemist. He is professor of nutrigenomics at the Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences in Olsztyn, Poland. Biography Carlberg was born in Hamburg, Germany. He attended school at Bremen, Germany, graduating in 1981 with Abitur at the Gymnasium an der Bördestrasse. From 1982 to 1987, he studied Physics and Biochemistry at the Free University of Berlin, Germany, finishing with a diploma in biochemistry. Thereafter he worked in the team of Burghardt Wittig and in 1989 received his PhD for his studies on the interaction of polymerases with DNA secondary structures at the Free University of Berlin.

(See a Problem?)

Carsten Carlberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Two nuclear signalling pathways for vitamin D (1993) (528)
Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. (1997) (437)
The vitamin D receptor. (2007) (437)
The Nuclear Receptor for Melatonin Represses 5-Lipoxygenase Gene Expression in Human B Lymphocytes (*) (1995) (269)
Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. (1995) (258)
Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor (2006) (250)
RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. (1994) (232)
Vitamin D receptor signaling mechanisms: Integrated actions of a well-defined transcription factor (2013) (229)
Comprehensive Analysis of PPARα-Dependent Regulation of Hepatic Lipid Metabolism by Expression Profiling (2007) (211)
Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy (2011) (207)
VDR‐Alien: a novel, DNA‐selective vitamin D3 receptor‐corepressor partnership (2000) (191)
Gene regulation by vitamin D3. (1998) (187)
Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. (2001) (185)
The Human Peroxisome Proliferator-activated Receptor δ Gene is a Primary Target of 1α,25-Dihydroxyvitamin D3 and its Nuclear Receptor (2005) (182)
Mechanisms of nuclear signalling by vitamin D3. Interplay with retinoid and thyroid hormone signalling. (1995) (180)
The orphan receptor family RZR/ROR, melatonin and 5‐lipoxygenase: An unexpected relationship (1995) (179)
Vitamins as hormones. (2007) (177)
Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent Mechanism* (2011) (175)
DICKKOPF-4 is induced by TCF/β-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1α,25-dihydroxyvitamin D3 (2008) (163)
Interaction between retinoic acid and vitamin D signaling pathways. (1993) (161)
Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. (2005) (157)
25-Hydroxyvitamin D3 is an agonistic vitamin D receptor ligand (2010) (154)
Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation (1995) (142)
Gene Regulation by Melatonin (2000) (140)
Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. (2003) (139)
Vitamin D3-thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation (1994) (138)
A role of melatonin in neuroectodermal‐mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors (2005) (125)
Inactivation of zinc finger transcription factors provides a mechanism for a gene regulatory role of nitric oxide (2000) (118)
Profiling of promoter occupancy by PPARα in human hepatoma cells via ChIP-chip analysis (2010) (117)
Genome-wide (over)view on the actions of vitamin D (2014) (117)
Cyclical Chromatin Looping and Transcription Factor Association on the Regulatory Regions of the p21 (CDKN1A) Gene in Response to 1α,25-Dihydroxyvitamin D3*S⃞ (2009) (114)
Current status of vitamin D signaling and its therapeutic applications. (2012) (112)
A genomic perspective on vitamin D signaling. (2009) (111)
Identification of Natural Monomeric Response Elements of the Nuclear Receptor RZR/ROR. THEY ALSO BIND COUP-TF HOMODIMERS* (1996) (109)
The Human Hyaluronan Synthase 2 Gene Is a Primary Retinoic Acid and Epidermal Growth Factor Responding Gene* (2005) (108)
The concept of the personal vitamin D response index (2018) (108)
Thiazolidine Diones, Specific Ligands of the Nuclear Receptor Retinoid Z Receptor/Retinoid Acid Receptor-related Orphan Receptor α with Potent Antiarthritic Activity* (1996) (107)
Patterns of Genome-Wide VDR Locations (2014) (106)
Regulation of multiple insulin-like growth factor binding protein genes by 1α,25-dihydroxyvitamin D3 (2005) (106)
cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. (1994) (105)
Molecular basis of the selective activity of vitamin D analogues (2003) (104)
Nutrigenomics of Vitamin D (2019) (103)
Selective use of multiple vitamin D response elements underlies the 1 α,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene (2007) (103)
All natural DR3-type vitamin D response elements show a similar functionality in vitro. (2000) (97)
Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta. (2007) (97)
Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. (1994) (96)
The first genome-wide view of vitamin D receptor locations and their mechanistic implications. (2012) (92)
The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. (1998) (88)
Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF (2015) (87)
Sensitive induction of apoptosis in breast cancer cells by a novel 1,25‐dihydroxyvitamin D3 analogue shows relation to promoter selectivity (1997) (87)
Differential apoptotic response of human melanoma cells to 1α,25-dihydroxyvitamin D3 and its analogues (1998) (87)
The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. (2005) (87)
Primary Vitamin D Target Genes Allow a Categorization of Possible Benefits of Vitamin D3 Supplementation (2013) (86)
An update on vitamin D signaling and cancer. (2020) (85)
Meta-analysis of primary target genes of peroxisome proliferator-activated receptors (2007) (80)
Zinc Finger Transcription Factors as Molecular Targets for Nitric Oxide-mediated Immunosuppression: Inhibition of IL-2 Gene Expression in Murine Lymphocytes (1999) (79)
1,25‐dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3‐E1 cells by direct regulation of cystathionine β‐synthase (2011) (78)
Primary effect of 1α,25(OH)₂D₃ on IL-10 expression in monocytes is short-term down-regulation. (2010) (76)
Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter (2005) (75)
Inhibition of cytokine secretion from adipocytes by 1,25‐dihydroxyvitamin D3 via the NF‐κB pathway (2012) (75)
Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. (2002) (74)
Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages (2012) (74)
Dataset integration identifies transcriptional regulation of microRNA genes by PPARγ in differentiating mouse 3T3-L1 adipocytes (2012) (73)
Antagonistic Action of a 25-Carboxylic Ester Analogue of 1α,25-Dihydroxyvitamin D3 Is Mediated by a Lack of Ligand-induced Vitamin D Receptor Interaction with Coactivators* (2000) (73)
Identification of pregnane X receptor binding sites in the regulatory regions of genes involved in bile acid homeostasis. (2005) (72)
Different molecular mechanisms of vitamin D(3) receptor antagonists. (2001) (71)
Structural Determinants of the Agonist-independent Association of Human Peroxisome Proliferator-activated Receptors with Coactivators* (2005) (71)
Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to trichostatin A and 1α,25-dihydroxyvitamin D3 (2007) (70)
Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. (2000) (69)
Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression (2012) (69)
The Insulin-like Growth Factor-binding Protein 1 Gene Is a Primary Target of Peroxisome Proliferator-activated Receptors* (2006) (68)
Differential effects of 1α,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes (2012) (68)
The down-regulation of the human MYC gene by the nuclear hormone 1alpha,25-dihydroxyvitamin D3 is associated with cycling of corepressors and histone deacetylases. (2010) (67)
The vitamin D(3) receptor in the context of the nuclear receptor superfamily : The central role of the retinoid X receptor. (1996) (67)
Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists. (2000) (66)
Central role of VDR conformations for understanding selective actions of vitamin D3 analogues (2001) (66)
Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells (2010) (65)
Thyroid hormone receptor functions as monomeric ligand-induced transcription factor on octameric half-sites. Consequences also for dimerization. (1994) (64)
Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608. (1998) (64)
Characterization of DNA Complexes Formed by the Nuclear Receptor Constitutive Androstane Receptor* (2003) (64)
The physiology of vitamin D—far more than calcium and bone (2014) (64)
The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. (1995) (63)
Vitamin D and evolution: pharmacologic implications. (2020) (62)
Epigenetic corruption of VDR signalling in malignancy. (2006) (62)
Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands (2002) (62)
Primary Vitamin D Target Genes of Human Monocytes (2019) (61)
Relevance of Vitamin D Receptor Target Genes for Monitoring the Vitamin D Responsiveness of Primary Human Cells (2015) (59)
Functional characterization of vitamin D responding regions in the human 5-Lipoxygenase gene. (2007) (59)
Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes. (2013) (57)
RXR-dependent and RXR-independent transactivation by retinoic acid receptors. (1993) (57)
Cellular Content of UDP-N-acetylhexosamines Controls Hyaluronan Synthase 2 Expression and Correlates with O-Linked N-Acetylglucosamine Modification of Transcription Factors YY1 and SP1* (2011) (56)
Functional characterization of a 1,25-dihydroxyvitamin D3 receptor binding site found in the rat atrial natriuretic factor promoter. (1996) (56)
Vitamin D and Its Synthetic Analogs (2019) (56)
Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists. (2002) (55)
Vitamin D Signaling in the Context of Innate Immunity: Focus on Human Monocytes (2019) (55)
Molecular endocrinology of vitamin D on the epigenome level (2017) (55)
Dynamics of nuclear receptor target gene regulation (2010) (55)
An integrated biological approach to nuclear receptor signaling in physiological control and disease. (2006) (54)
Response element selectivity for heterodimerization of vitamin D receptors with retinoic acid and retinoid X receptors. (1994) (54)
Key Vitamin D Target Genes with Functions in the Immune System (2020) (54)
Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes (2016) (53)
Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives. (2001) (53)
Identification of a vitamin D receptor homodimer-type response element in the rat calcitriol 24-hydroxylase gene promoter. (1994) (52)
Mechanism of 1α,25-dihydroxyvitamin D(3)-dependent repression of interleukin-12B. (2011) (52)
Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs. (1999) (52)
Structure Activity Relationship of Carboxylic Ester Antagonists of the Vitamin D3 Receptor (2000) (52)
The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: Homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors (1994) (51)
Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein. (2005) (50)
In vivo response of the human epigenome to vitamin D: A Proof-of-principle study (2018) (50)
Vitamin D receptor(s): In the nucleus but also at membranes? (2020) (49)
Lipid soluble vitamins in gene regulation (1999) (48)
Carboxylic ester antagonists of 1α,25-dihydroxyvitamin D3 show cell-specific actions (2000) (48)
Vitamin D receptor 2016: novel ligands and structural insights (2016) (48)
Vitamin D Receptor Agonists Specifically Modulate the Volume of the Ligand-binding Pocket* (2006) (47)
Vitamin D-retinoid association: molecular basis and clinical applications. (1996) (47)
Potentiation by vitamin D analogs of TNFα and ceramide-induced apoptosis in MCF-7 cells is associated with activation of cytosolic phospholipase A2 (1999) (47)
Integration of the Activation of the Human Hyaluronan Synthase 2 Gene Promoter by Common Cofactors of the Transcription Factors Retinoic Acid Receptor and Nuclear Factor κB* (2007) (47)
Differential nuclear receptor signalling from DR4‐type response elements (2002) (46)
Regulation of the human p 21 ( waf 1 / cip 1 ) gene promoter via multiple binding sites for p 53 and the vitamin D 3 receptor (2006) (46)
Healthy Nordic diet downregulates the expression of genes involved in inflammation in subcutaneous adipose tissue in individuals with features of the metabolic syndrome. (2015) (46)
Regulation of the Hyaluronan Synthase 2 Gene by Convergence in Cyclic AMP Response Element-binding Protein and Retinoid Acid Receptor Signaling* (2009) (46)
Identification of a vitamin D3 response element in the fibronectin gene that is bound by a vitamin D3 receptor homodimer (1996) (46)
Vitamin D receptor ligands: the impact of crystal structures (2012) (46)
Primary 1,25-Dihydroxyvitamin D3 Response of the Interleukin 8 Gene Cluster in Human Monocyte- and Macrophage-Like Cells (2013) (45)
Selective regulation of biological processes by vitamin D based on the spatio-temporal cistrome of its receptor. (2017) (45)
Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases. (2001) (45)
Changes in vitamin D target gene expression in adipose tissue monitor the vitamin D response of human individuals. (2014) (45)
Positive and negative interaction of 1,25‐dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis (1999) (44)
The impact of the vitamin D-modulated epigenome on VDR target gene regulation. (2018) (44)
RXR-independent action of the receptors for thyroid hormone, retinoid acid and vitamin D on inverted palindromes. (1993) (44)
Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators. (2000) (44)
Gene regulatory potential of nonsteroidal vitamin D receptor ligands. (2005) (43)
In vivo transcriptome changes of human white blood cells in response to vitamin D (2019) (43)
Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands. (2006) (42)
Mechanisms of Nuclear Signalling by Vitamin D3 (1995) (41)
Vitamin D Genomics: From In Vitro to In Vivo (2018) (41)
An aryl hydrocarbon receptor conformation acts as the functional core of nuclear dioxin signaling. (2000) (41)
The Number of Vitamin D Receptor Binding Sites Defines the Different Vitamin D Responsiveness of the CYP24 Gene in Malignant and Normal Mammary Cells* (2010) (40)
Ligand-mediated conformational changes of the VDR are required for gene transactivation (2004) (40)
Dissecting high from low responders in a vitamin D3 intervention study (2015) (39)
The high affinity ligand binding conformation of the nuclear 1,25-dihydroxyvitamin D3 receptor is functionally linked to the transactivation domain 2 (AF-2). (1996) (39)
Functional Characterization of a Novel Type of 1α,25-Dihydroxyvitamin D3Response Element Identified in the Mouse c-fosPromoter (1997) (39)
Variations in the Ghrelin Receptor Gene Associate with Obesity and Glucose Metabolism in Individuals with Impaired Glucose Tolerance (2008) (38)
Design principles of nuclear receptor signaling: how complex networking improves signal transduction (2010) (38)
Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view. (2015) (38)
Functional conformations of the nuclear 1alpha,25-dihydroxyvitamin D3 receptor. (1997) (37)
Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes (2017) (37)
Molecular evaluation of vitamin D responsiveness of healthy young adults (2017) (37)
Thyroid hormone and retinoic acid receptors form heterodimers with retinoid X receptors on direct repeats, palindromes, and inverted palindromes. (1994) (37)
New vitamin D receptor ligands (2003) (36)
Epigenomic PU.1-VDR crosstalk modulates vitamin D signaling. (2017) (36)
Identification and characterization of a vitamin D3 response element of chicken carbonic anhydrase-II. (1994) (36)
Cross-repression, a Functional Consequence of the Physical Interaction of Non-liganded Nuclear Receptors and POU Domain Transcription Factors* (2002) (35)
Coordinate induction of PPAR alpha and SREBP2 in multifunctional protein 2 deficient mice. (2008) (34)
The highly conserved region of the co-repressor Sin3A functionally interacts with the co-repressor Alien. (2004) (34)
The genes of the coactivator TIF2 and the corepressor SMRT are primary 1α,25(OH)2D3 targets (2004) (34)
Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system. (2014) (33)
Vitamin D-dependent chromatin association of CTCF in human monocytes. (2016) (33)
The critical role of carboxy-terminal amino acids in ligand-dependent and -independent transactivation of the constitutive androstane receptor. (2003) (33)
Corrigendum to “Primary effect of 1α,25(OH)2D3 on IL-10 expression in monocytes is short-term down-regulation” [Biochim. Biophys. Acta 1803 (2010) 1276–86] (2011) (33)
The role of the T-box for the function of the vitamin D receptor on different types of response elements. (1998) (33)
The vitamin D-dependent transcriptome of human monocytes (2016) (32)
Molecular Approaches for Optimizing Vitamin D Supplementation. (2016) (32)
Controlling the chromatin organization of vitamin D target genes by multiple vitamin D receptor binding sites (2007) (32)
Characterization of Genomic Vitamin D Receptor Binding Sites through Chromatin Looping and Opening (2014) (31)
The impact of chromatin organization of vitamin D target genes. (2006) (31)
Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor. (2003) (31)
The impact of functional vitamin D(3) receptor conformations on DNA-dependent vitamin D(3) signaling. (2000) (29)
Time-Resolved Expression Profiling of the Nuclear Receptor Superfamily in Human Adipogenesis (2010) (29)
Analysis of the 5-lipoxygenase promoter and characterization of a vitamin D receptor binding site. (2006) (29)
Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor. (2003) (28)
The concept of multiple vitamin D signaling pathways. (1996) (28)
Interaction of Two Novel 14‐Epivitamin D3 Analogs with Vitamin D3 Receptor‐Retinoid X Receptor Heterodimers on Vitamin D3 Responsive Elements (2001) (28)
A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling. (2004) (28)
Cyclical regulation of the insulin-like growth factor binding protein 3 gene in response to 1α,25-dihydroxyvitamin D3 (2010) (27)
Retraction Notice to: Population-Level Transcription Cycles Derive from Stochastic Timing of Single-Cell Transcription (2010) (27)
Gene regulatory potential of 1α,25‐dihydroxyvitamin D3 analogues with two side chains (2001) (26)
Multiplex Eukaryotic Transcription (In)activation: Timing, Bursting and Cycling of a Ratchet Clock Mechanism (2015) (26)
Agonist-dependent and Agonist-independent Transactivations of the Human Constitutive Androstane Receptor Are Modulated by Specific Amino Acid Pairs* (2004) (25)
Mechanisms of Gene Regulation (2013) (24)
The transcriptional regulator BCL6 participates in the secondary gene regulatory response to vitamin D. (2015) (24)
ETS transcription factor family member GABPA contributes to vitamin D receptor target gene regulation (2017) (24)
9-cis-retinoic acid is a natural antagonist for the retinoic acid receptor response pathway. (1993) (23)
Modulation of vitamin D signaling by the pioneer factor CEBPA. (2019) (23)
Vitamin D and Its Target Genes (2022) (23)
RETRACTED: Population-Level Transcription Cycles Derive from Stochastic Timing of Single-Cell Transcription (2009) (23)
Vitamin D: A Micronutrient Regulating Genes. (2019) (22)
High‐affinity nuclear receptor binding of 20‐epi analogues of 1,25‐dihydroxyvitamin D3 correlates well with gene activation (1996) (21)
Genome-wide effects of chromatin on vitamin D signaling. (2020) (21)
Cyclin C is a primary 1α,25‐dihydroxyvitamin D3 responding gene (2000) (21)
Skin colour and vitamin D: An update (2020) (21)
A Role for the PPARγ in Cancer Therapy (2008) (21)
Molecular mechanism of allosteric communication in the human PPARα‐RXRα heterodimer (2010) (20)
Potent gene regulatory and antiproliferative activities of 20‐methyl analogues of 1,25 dihydroxyvitamin D3 (1996) (20)
1α,25‐Dihydroxyvitamin D3 receptor as a mediator of transrepression of retinoid signaling (1997) (19)
Effects of a healthy Nordic diet on gene expression changes in peripheral blood mononuclear cells in response to an oral glucose tolerance test in subjects with metabolic syndrome: a SYSDIET sub-study (2016) (19)
The ASAP2 gene is a primary target of 1,25-dihydroxyvitamin D3 in human monocytes and macrophages (2014) (19)
Using chromatin immunoprecipitation to monitor 1α,25-dihydroxyvitamin D3-dependent chromatin activity on the human CYP24 promoter (2004) (19)
Functional characterization of a novel type of 1 alpha,25-dihydroxyvitamin D3 response element identified in the mouse c-fos promoter. (1997) (19)
Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA. (1997) (18)
Gene Regulatory Scenarios of Primary 1,25-Dihydroxyvitamin D3 Target Genes in a Human Myeloid Leukemia Cell Line (2013) (18)
Vitamin D and the risk for cancer: a molecular analysis. (2021) (18)
The Impact of Chromatin (2016) (18)
Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT121 Mice (2019) (17)
The gene for the transcription factor BHLHE40/DEC1/stra13 is a dynamically regulated primary target of the vitamin D receptor (2013) (17)
What do we learn from the genome-wide perspective on vitamin D3? (2015) (17)
Machine learning approaches infer vitamin D signaling: Critical impact of vitamin D receptor binding within topologically associated domains (2019) (16)
Melatonin receptor ligands (1999) (16)
Mechanisms of Gene Regulation (2014) (16)
Common and personal target genes of the micronutrient vitamin D in primary immune cells from human peripheral blood (2020) (16)
The need for education in personalized medicine. (2012) (15)
Peroxisome proliferator-activated receptor alpha controls hepatic heme biosynthesis through ALAS1. (2009) (15)
Effects of a healthy Nordic diet on plasma 25-hydroxyvitamin D concentration in subjects with metabolic syndrome: a randomized, placebo-controlled trial (SYSDIET) (2014) (15)
Cell cycle regulatory effects of retinoic Acid and forskolin are mediated by the cyclin C gene. (2009) (14)
The potent anti‐proliferative effect of 20‐EPI analogues of 1,25 dihydroxyvitamin D3 in human breast‐cancer MCF‐7 cells is related to promoter selectivity (1996) (14)
Subcellular localisation of BAG-1 and its regulation of vitamin D receptor-mediated transactivation and involucrin expression in oral keratinocytes: implications for oral carcinogenesis. (2007) (14)
A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes (2021) (13)
An Isocaloric Nordic Diet Modulates RELA and TNFRSF1A Gene Expression in Peripheral Blood Mononuclear Cells in Individuals with Metabolic Syndrome—A SYSDIET Sub-Study (2019) (12)
Time-Resolved Gene Expression Analysis Monitors the Regulation of Inflammatory Mediators and Attenuation of Adaptive Immune Response by Vitamin D (2022) (12)
Inhibitory effect of uremic solutions on protein‐DNA‐complex formation of the vitamin D receptor and other members of the nuclear receptor superfamily (1999) (12)
Endocrine functions of vitamin D (2017) (11)
Structure activity relationship of carboxylic ester antagonists of the vitamin D(3) receptor. (2000) (11)
Metabolism of the vitamin D3 analogue EB1089 alters receptor complex formation and reduces promoter selectivity (1998) (11)
Nuclear Signalling of Melatonin (1997) (10)
The Histone Code (2018) (10)
1 , 25-Dihydroxyvitamin D 3 Influences Cellular Homocysteine Levels in Murine Preosteoblastic MC 3 T 3E 1 Cells by Direct Regulation of Cystathionine b-Synthase (2011) (10)
Vitamin D in the Context of Evolution (2022) (9)
The impact of transcriptional cycling on gene regulation (2010) (9)
Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity (1998) (9)
Healthy Nordic Diet Modulates the Expression of Genes Related to Mitochondrial Function and Immune Response in Peripheral Blood Mononuclear Cells from Subjects with Metabolic Syndrome-A SYSDIET Sub-Study. (2019) (8)
Vitamin D Treatment Sequence Is Critical for Transcriptome Modulation of Immune Challenged Primary Human Cells (2021) (8)
Single thyroid hormone receptor monomers are competent for co-activator-mediated transactivation. (2001) (8)
Screening for PPAR Responsive Regulatory Modules in Cancer (2008) (7)
The induction and functions of murine T-helper cell subsets. (1995) (7)
Impact of Epigenetics on Complications of Fanconi Anemia: The Role of Vitamin D-Modulated Immunity (2020) (7)
Tracing the molecular basis of transcriptional dynamics in noisy data by using an experiment-based mathematical model (2014) (7)
CHAPTER 18 – Molecular Basis of the Diversity of Vitamin D Target Genes (2005) (7)
Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions. (2000) (7)
The antiproliferative effect of vitamin D3 analogues. (1996) (7)
From pharmacogenomics to integrated personal omics profiling: a gap in implementation into healthcare. (2014) (6)
The vitamin D3 receptor in the context of the nuclear receptor superfamily (2007) (6)
Functional conformations of the nuclear 1 a ,25-dihydroxyvitamin D 3 receptor (1997) (6)
The genes of the coactivator TIF 2 and the corepressor SMRT are primary 1 , 25 ( OH ) 2 D 3 targets (5)
Highlights from the 5th International Conference on Vitamin D Deficiency, Nutrition and Human Health, Abu Dhabi, United Arab Emirates, March 24–25, 2016 (2018) (5)
Nutrigenomics: How Science Works (2020) (5)
Replacing saturated fat with polyunsaturated fat modulates peripheral blood mononuclear cell gene expression and pathways related to cardiovascular disease risk using a whole transcriptome approach. (2021) (4)
The Insulin-like Growth Factor-binding Protein 1 Gene Is a Primary Target of Peroxisome (2006) (4)
Transcriptome-Wide Profile of 25-Hydroxyvitamin D3 in Primary Immune Cells from Human Peripheral Blood (2021) (4)
Cyclin C is a primary 1alpha,25-dihydroxyvitamin D(3) responding gene. (2000) (4)
Human Epigenetics: How Science Works (2019) (4)
Genome-wide view on the physiology of vitamin D (2014) (4)
Vitamin D and Pigmented Skin (2022) (3)
Target Genes of Vitamin D: Spatio-temporal Interaction of Chromatin, VDR, and Response Elements (2011) (3)
1 alpha,25-dihydroxyvitamin D3 receptor as a mediator of transrepression of retinoid signaling. (1997) (3)
promoter via multiple binding sites for p53 and the vitamin D 3 receptor (2006) (3)
Chronic Inflammation and Metabolic Stress (2020) (3)
Gene-Regulatory Potential of 25-Hydroxyvitamin D3 and D2 (2022) (3)
Chromatin Modifiers (2020) (3)
Randomized controlled trial on the effectiveness of web-based Genomics Nursing Education Intervention for undergraduate nursing students: a study protocol. (2020) (3)
A Single Vitamin D3 Bolus Supplementation Improves Vitamin D Status and Reduces Proinflammatory Cytokines in Healthy Females (2022) (2)
' s personal copy Peroxisome Proliferator-Activated Receptor α Controls Hepatic Heme Biosynthesis Through ALAS 1 (2009) (2)
Nutrition and Common Diseases (2020) (2)
Switching Genes on and off: The Example of Nuclear Receptors (2014) (2)
A Single Oral Vitamin D3 Bolus Reduces Inflammatory Markers in Healthy Saudi Males (2022) (2)
Hypertension, Atherosclerosis and Dyslipidemias (2016) (2)
What Is Epigenomics (2018) (2)
Cancer Biology: How Science Works (2021) (2)
Dynamic nature of transcriptional regulation of nuclear receptor target genes in the context of chromatin organization (2011) (2)
What Do We Learn from the Genome-wide Perspective on Vitamin D 3 ? (2014) (2)
Diversity of Vitamin D Target Genes (2010) (2)
Highlights from the 6th International Conference on Vitamin D Deficiency, “Nutrition and Human Health”, Abu Dhabi, United Arab Emirates, March 9-10, 2017 (2018) (2)
Adaption of the Human Genome to Dietary Changes (2016) (1)
Genes and Chromatin (2020) (1)
Mapping the Genome (2016) (1)
Mechanisms of Gene Regulation: How Science Works (2020) (1)
Sensing Nutrition (2020) (1)
Dynamic nature of transcriptional regulation of nuclear receptor target genes in the context of chromatin organization. (2011) (1)
Identification of a Vitamin D 3 Response in the Fibronectin Gene That I s Bound by a Vitamin D 3 Receptor Homodimer (2003) (1)
Genome-Wide Principles of Gene Regulation (2020) (1)
Nutrition and epigenetic programming (2022) (1)
The Impact of Whole Genome In Silico Screening for Nuclear Receptor‐Binding Sites in Systems Biology (2010) (1)
2 gene is a primary target of 1 , 25-dihydroxyvitamin D 3 in uman monocytes and macrophages (2013) (1)
Chromatin (2019) (1)
Epigenome-Wide Effects of Vitamin D (2019) (1)
Retraction notice to “Peroxisome proliferator-activated receptor α controls hepatic heme biosynthesis through ALAS1” J. Mol. Biol. 388/2 (2010) 225–238. (2010) (1)
ANALYSIS OF GENOME-WIDE DATA ON TRANSCRIPTION FACTOR BINDING AND THEIR TARGET GENE REGULATION: A CASE STUDY OF LIVER X RECEPTORS (2011) (1)
Additions and corrections (1992) (0)
Insulin Resistance and Diabetes (2020) (0)
Tumor Microenvironment (2021) (0)
Epigenomics of Immune Function (2018) (0)
Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes (2017) (0)
The murine hair follicle is a melatonin target (2008) (0)
Heart Disease and the Metabolic Syndrome (2020) (0)
Metastasis and Cachexia (2021) (0)
Transcription Factors and Signal Transduction (2020) (0)
Human Genomic Variation (2020) (0)
Multi-step Tumorigenesis and Genome Instability (2021) (0)
Oncogenes and Signal Transduction (2021) (0)
Design principles of nuclear receptor signalling: How complex networking improves signal transduction (2011) (0)
Architecture of Cancer Therapies (2021) (0)
Methods and Applications of Epigenomics (2018) (0)
The Structure of Chromatin (2018) (0)
Obesity (2020) (0)
The anti-psoriatic 1.25-dihydroxyvitamin D, analogue calcipotriol (MC903) as well as the analogues EB1089 and KH1060 induce vitamin D receptor mediated transactivation: Different ligand sensitivity of receptor homo- and heterodimers (1994) (0)
Cyclin C is a primary 1α,25-dihydroxyvitamin D3 responding genePatsie Polly and Carina Danielsson contributed equally to this work. (2000) (0)
Cancer Immunity (2021) (0)
Chromatin Remodelers and Organizers (2018) (0)
Modulation of nuclear vitamin D signalling by retinoids (2000) (0)
Interference of the Human Genome with Nutrients (2020) (0)
Vitamin D and Chromatin (2018) (0)
Chromatin Modifying Proteins and RNAs (2019) (0)
Basal Transcriptional Machinery (2020) (0)
Linking Signal Transduction and Gene Regulation (2016) (0)
Regulatory Impact of Non-coding RNA (2020) (0)
Erratum to: Effects of a healthy Nordic diet on plasma 25-hydroxyvitamin D concentration in subjects with metabolic syndrome: a randomized, controlled trial (SYSDIET) (2014) (0)
Vitamin D and the epigenome (2014) (0)
A Key Transcription Factor Family: Nuclear Receptors (2020) (0)
Population Epigenomics and Aging (2018) (0)
Cholera toxin (CT) and cAMP upregulate IL-4 gene expression in Th0 cells (1993) (0)
Genome-wide effects of vitamin D on chromatin (2019) (0)
Tumor Suppressor Genes and Cell Fate Control (2021) (0)
Aging and Cancer (2021) (0)
Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages (2012) (0)
Highlights from the 21st Workshop on Vitamin D in Barcelona, May 2018 (2019) (0)
The Metabolic Syndrome (2016) (0)
Effects of a healthy Nordic diet on gene expression changes in peripheral blood mononuclear cells in response to an oral glucose tolerance test in subjects with metabolic syndrome: a SYSDIET sub-study (2016) (0)
Population Epigenetics and Aging (2019) (0)
Epigenetics (2020) (0)
Monitoring genome-wide chromatin accessibility by formaldehyde-assisted isolation of regulatory elements sequencing (FAIRE-seq) (2020) (0)
Histone Modifications (2019) (0)
Antiproliferative response of two human primary melanoma cell lines to 1,25-dihydroxyvitamin D3 and its analogues (1998) (0)
Embryogenesis and Cellular Differentiation (2018) (0)
Nutritional Signaling and Aging (2020) (0)
Vitamin D receptor signaling and its therapeutic implications : Genome-wide and structural view 1 (0)
New Insights to Nuclear Receptor Gene Regulation from Analysis of their Response Elements in Target Genes (2010) (0)
Epigenome-Environment Interactions and Their Therapy (2019) (0)
The Basal Transcriptional Machinery (2014) (0)
Overview: What Is Gene Expression? (2016) (0)
Note on Carlberg and Seuter ( 2010 ) Dynamics of nuclear receptor target gene regulation , (2010) (0)
Chromatin Remodeling and Organization (2020) (0)
DNA Methylation (2019) (0)
Introduction to Cancer (2021) (0)
Glucose Homeostasis, Insulin Resistance and β Cell Failure (2016) (0)
Cancer Genomics (2021) (0)
Carboxylic ester antagonists of 1K K,25-dihydroxyvitamin D 3 show cell-speci¢c actions (2000) (0)
Nutritional Epigenetics (2019) (0)
Principles of gene regulation by bioactive lipids through members of the nuclear receptor superfamily (2004) (0)
Clarification for The impact of transcriptional cycling on gene regulation (2011) (0)
Epigenetics of Immune Function (2019) (0)
Cancer Epigenomics (2021) (0)

This paper list is powered by the following services:

Other Resources About Carsten Carlberg

en.wikipedia.org

What Schools Are Affiliated With Carsten Carlberg?

Carsten Carlberg is affiliated with the following schools:

Carsten Carlberg's Academic­Influence.com Rankings